Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VITdALIZE-KIDS: High-dose Vitamin D in PICU
NCT03742505Phase 3Completed
- Sponsor
- Children's Hospital of Eastern Ontario
- Start
- Jun 2019
- Primary completion
- Oct 2024
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Vitamin D deficiency (VDD) comparing Vitamin D with Placebo (2 arms). Primary endpoint: Health related quality of life at 28 days. Started Jun 2019; status: completed.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT03742505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03742505.